Tekmira Pharmaceuticals (TKMR) is a small-cap pharmaceutical company with a very interesting pipeline. The company has many different drugs in many stages of development. As these drugs progress, so too should the stock price at Tekmira. Tekmira represents a very nice mix of medium- to long-term catalysts that should help to drive shareholder growth over the next few years.
The company has a multitude of very interesting products in its pipeline.
(click to enlarge)
As you can see, most of the drugs in the pipeline are in the early stages of development.
There are many different, promising development programs in Tekmira's pipeline, however, four are highlighted below. Each of these programs have the potential to help drive long term...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|
|PRO Top long ideas returned 21.7% in 2016**|